Related Experiment Videos

Interferon-gamma production and HLA-DR expression in patients with retinitis pigmentosa

R L Hendricks1, G A Fishman

  • 1Department of Ophthalmology, Lions of Illinois Eye Research Institute, University of Illinois School of Medicine, Chicago 60612.

Experimental Eye Research
|December 1, 1987
PubMed

Insights

This study found no deficiencies in interferon-gamma (IFN-gamma) production or HLA-DR antigen expression on monocytes in retinitis pigmentosa (RP) patients. Cell-mediated immune abnormalities were not detected in RP patients.

Area of Science:

  • Immunology
  • Ophthalmology
  • Genetics

Background:

  • Previous studies suggested immune system involvement in retinitis pigmentosa (RP).
  • Reports indicated deficient interferon-gamma (IFN-gamma) production and reduced HLA-DR antigen expression on monocytes in RP patients.
  • Our prior research did not find deficient IFN-gamma production in RP lymphocytes.

Purpose of the Study:

  • To investigate cell-mediated immunity in retinitis pigmentosa (RP).
  • To determine HLA-DR antigen expression on monocytes and IFN-gamma production in RP patients.
  • To confirm or refute previous findings of immune abnormalities in RP.

Main Methods:

  • Analysis of HLA-DR antigen expression on monocytes using two-color immunofluorescence staining and flow cytometry.
  • Assessment of IFN-gamma production by lymphocytes using a radioimmunoassay test kit.
  • Inclusion of a large, well-defined cohort of RP patients, including autosomal dominant and recessive subtypes.

Main Results:

  • Confirmed previous findings of normal IFN-gamma production by lymphocytes in RP patients.
  • Demonstrated normal expression of HLA-DR antigens on monocytes from RP patients.
  • No significant cell-mediated immune abnormalities were detected in the studied RP population.

Conclusions:

  • Lymphocytes from RP patients exhibit normal IFN-gamma production.
  • Monocytes from RP patients display normal HLA-DR antigen expression.
  • This study did not find evidence of significant cell-mediated immune dysfunction in retinitis pigmentosa.

Related Concept Videos